MINI FUTURE SHORT - STRYKER CORP. Stock

Certificat

DE000PN8BR71

Market Closed - Bid/Ask 02:50:27 2024-07-17 pm EDT
5.94 EUR -5.86% Intraday chart for MINI FUTURE SHORT - STRYKER CORP.
Current month+8.98%
1 month+15.99%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-17 5.94 -5.86%
24-07-16 6.31 -6.38%
24-07-15 6.74 +18.87%
24-07-12 5.67 -3.41%
24-07-11 5.87 -3.29%

Real-time Boerse Frankfurt Warrants

Last update July 17, 2024 at 02:50 pm EDT

More quotes

Static data

Product typeWarrant Knock-Out con Stop Loss
Buy / SellPUT
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN8BR7
ISINDE000PN8BR71
Date issued 2023-09-13
Strike 401.4 $
Maturity Unlimited
Parity 10 : 1
Emission price 9.4
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 13.93
Lowest since issue 3.76
Spread 0.03
Spread %0.51%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
333.4 USD
Average target price
372.7 USD
Spread / Average Target
+11.79%
Consensus